Abuse Deterrent Access Act of 2018
USA115th CongressHR-5582| House
| Updated: 6/13/2018
Earl L. "Buddy" Carter
Republican Representative
Georgia
Cosponsors (6)
Ways and Means Committee, Finance Committee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Abuse Deterrent Access Act of 2018 (Sec. 2) This bill requires the Centers for Medicare & Medicaid Services to report to Congress on the adequacy of access to abuse-deterrent opioid formulations for individuals with chronic pain enrolled in a prescription drug plan under Medicare or Medicare Advantage (MA). The report must account for any barriers preventing enrollees from accessing such formulations under Medicare or MA.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Committee Consideration and Mark-up Session Held.
Ordered to be Reported (Amended) by Voice Vote.
Placed on the Union Calendar, Calendar No. 556.
Committee on Ways and Means discharged.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-721, Part I.
Mr. Walden moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5061-5063)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5582.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5061)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5061)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Finance.
Health
Congressional oversightDrug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth promotion and preventive careMedicarePrescription drugs
Abuse Deterrent Access Act of 2018
USA115th CongressHR-5582| House
| Updated: 6/13/2018
Abuse Deterrent Access Act of 2018 (Sec. 2) This bill requires the Centers for Medicare & Medicaid Services to report to Congress on the adequacy of access to abuse-deterrent opioid formulations for individuals with chronic pain enrolled in a prescription drug plan under Medicare or Medicare Advantage (MA). The report must account for any barriers preventing enrollees from accessing such formulations under Medicare or MA.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Committee Consideration and Mark-up Session Held.
Ordered to be Reported (Amended) by Voice Vote.
Placed on the Union Calendar, Calendar No. 556.
Committee on Ways and Means discharged.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-721, Part I.
Mr. Walden moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5061-5063)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5582.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5061)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5061)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Finance.
Earl L. "Buddy" Carter
Republican Representative
Georgia
Cosponsors (6)
Ways and Means Committee, Finance Committee, Health Subcommittee, Energy and Commerce Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Congressional oversightDrug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth promotion and preventive careMedicarePrescription drugs